Andrew Cheng - Net Worth and Insider Trading
Andrew Cheng Net Worth
The estimated net worth of Andrew Cheng is at least $19 Million dollars as of 2024-11-29. Andrew Cheng is the President and CEO of Akero Therapeutics Inc and owns about 605,417 shares of Akero Therapeutics Inc (AKRO) stock worth over $19 Million. Details can be seen in Andrew Cheng's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Cheng has not made any transactions after 2024-11-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew Cheng
Andrew Cheng Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Cheng owns 3 companies in total, including Arbutus Biopharma Corp (ABUS) , Akero Therapeutics Inc (AKRO) , and Vera Therapeutics Inc (VERA) .
Click here to see the complete history of Andrew Cheng’s form 4 insider trades.
Insider Ownership Summary of Andrew Cheng
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | 2019-08-17 | director |
| AKRO | Akero Therapeutics Inc | 2024-11-01 | director & President & CEO |
| VERA | Vera Therapeutics Inc | 2021-05-13 | director |
Andrew Cheng Latest Holdings Summary
Andrew Cheng currently owns a total of 1 stock. Andrew Cheng owns 605,417 shares of Akero Therapeutics Inc (AKRO) as of November 1, 2024, with a value of $19 Million.
Latest Holdings of Andrew Cheng
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKRO | Akero Therapeutics Inc | 2024-11-01 | 605,417 | 32.17 | 19,476,265 |
Holding Weightings of Andrew Cheng
Andrew Cheng Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Cheng has made a total of 30 transactions in Akero Therapeutics Inc (AKRO) over the past 5 years, including 0 buys and 30 sells. The most-recent trade in Akero Therapeutics Inc is the sale of 108,366 shares on November 1, 2024, which brought Andrew Cheng around $3 Million.
Insider Trading History of Andrew Cheng
- 1
Andrew Cheng Trading Performance
Andrew Cheng Ownership Network
Andrew Cheng Owned Company Details
What does Arbutus Biopharma Corp do?
Who are the key executives at Arbutus Biopharma Corp?
Andrew Cheng is the director of Arbutus Biopharma Corp. Other key executives at Arbutus Biopharma Corp include Chief Financial Officer David C Hastings , Chief Business Officer Michael J. Mcelhaugh , and Chief Scientific Officer Michael J. Sofia .
Arbutus Biopharma Corp (ABUS) Insider Trades Summary
Over the past 18 months, Andrew Cheng made no insider transaction in Arbutus Biopharma Corp (ABUS). Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 10,164 shares made by Michael J. Mcelhaugh , a net sale of 9,982 shares made by Michael J. Sofia , and a net sale of 9,593 shares made by David C Hastings .
In summary, during the past 3 months, insiders sold 0 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 42,943 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 42,943 shares.
Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arbutus Biopharma Corp Insider Transactions
Andrew Cheng Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Cheng. You might contact Andrew Cheng via mailing address: 170 Harbor Way, 3rd Floor, C/o Akero Therapeutics, Inc., South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
